Cargando…
Genomic insights into the pathogenesis of Epstein–Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing
Epstein–Barr virus (EBV)-associated diffuse large B-cell lymphoma not otherwise specified (DLBCL NOS) constitute a distinct clinicopathological entity in the current World Health Organization (WHO) classification. However, its genomic features remain sparsely characterized. Here, we combine whole-ge...
Autores principales: | Gebauer, Niklas, Künstner, Axel, Ketzer, Julius, Witte, Hanno M., Rausch, Tobias, Benes, Vladimir, Zimmermann, Jürgen, Gebauer, Judith, Merz, Hartmut, Bernard, Veronica, Harder, Lana, Ratjen, Katharina, Gesk, Stefan, Peter, Wolfgang, Busch, Yannik, Trojok, Peter, von Bubnoff, Nikolas, Biersack, Harald, Busch, Hauke, Feller, Alfred C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155002/ https://www.ncbi.nlm.nih.gov/pubmed/34039950 http://dx.doi.org/10.1038/s41408-021-00493-5 |
Ejemplares similares
-
Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing
por: Künstner, Axel, et al.
Publicado: (2021) -
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways
por: Witte, Hanno M., et al.
Publicado: (2022) -
Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluation
por: Hertel, Nadine, et al.
Publicado: (2021) -
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
por: Witte, Hanno M., et al.
Publicado: (2023) -
Primary refractory plasmablastic lymphoma: A precision oncology approach
por: Witte, Hanno M., et al.
Publicado: (2023)